Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)

Historic Revenue for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to $396000.0.

  • Dianthus Therapeutics' Revenue fell 8176.8% to $396000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4230.55%. This contributed to the annual value of $6.2 million for FY2024, which is 12062.99% up from last year.
  • Latest data reveals that Dianthus Therapeutics reported Revenue of $396000.0 as of Q3 2025, which was down 8176.8% from $193000.0 recorded in Q2 2025.
  • Over the past 5 years, Dianthus Therapeutics' Revenue peaked at $2.2 million during Q3 2024, and registered a low of $193000.0 during Q2 2025.
  • Its 4-year average for Revenue is $1.0 million, with a median of $1.0 million in 2023.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 21126.76% in 2024, then crashed by 8964.04% in 2025.
  • Dianthus Therapeutics' Revenue (Quarter) stood at $1.2 million in 2022, then plummeted by 63.74% to $426000.0 in 2023, then soared by 211.27% to $1.3 million in 2024, then tumbled by 70.14% to $396000.0 in 2025.
  • Its last three reported values are $396000.0 in Q3 2025, $193000.0 for Q2 2025, and $1.2 million during Q1 2025.